Analysts Viewpoint
Days-to-cover ratio for DNLI surges to 7.85 due to rise in short interest
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Denali Therapeutics Inc revealed its President and CEO Watts Ryan J. unloaded Company’s shares for reported $7.43
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Denali Therapeutics Inc revealed its President and CEO Watts Ryan J. unloaded Company’s shares for reported $7.43
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Denali Therapeutics Inc. (NASDAQ:DNLI) does about 640.18K shares in volume on a normal day but saw 472397 shares change hands